Prevention of NAFLD in Hispanic Children
Prevention of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanic Children
3 other identifiers
interventional
103
1 country
1
Brief Summary
This is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
March 23, 2022
CompletedStudy Start
First participant enrolled
April 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
ExpectedMarch 13, 2026
February 1, 2026
4 years
March 15, 2022
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Percent Hepatic Steatosis by MRI-PDFF
The primary objective for the 12-month study is to test if an LFSD, compared to usual diet protects against increase in hepatic steatosis
12 month after start of intervention
Onset of NAFLD
The primary objective for the 24-month is to study to test if an LFSD protects against development of NAFLD (hepatic steatosis ≥ 5% and elevated ALT).
24 months after start of intervention
Secondary Outcomes (12)
Changes in markers of liver inflammation: ALT
Baseline, month 6, month 12, month 18, and month 24
Changes in markers of liver inflammation: AST
Baseline, month 6, month 12, month 18, and month 24
Changes in markers of liver inflammation: GGT
Baseline, month 12 and month 24
Changes in HbA1c
Baseline, month 12 and month 24
Changes in fasting triglycerides
Baseline, Month 6, Month 12, month 18 and month 24
- +7 more secondary outcomes
Study Arms (2)
Low Free Sugar Diet (LFSD) Intervention
EXPERIMENTALThe 1-year dietary intervention will be accomplished by adapting and extending a Social Cognitive Theory (SCT) guided low sugar intervention. SCT is a framework that helps explain how people regulate their behavior through control and reinforcement to achieve goal-directed behavior that can be maintained over time.
Usual Care Control
NO INTERVENTIONUsual Care (Control group): Parents of enrolled children in the usual care group will be provided printed material on healthy family lifestyle at the beginning of the study. The control group will complete all of the same research visits and assessments as the intervention group.
Interventions
Assessment of child's usual diet to assess sugar intake in relation to the total usual diet. Consultation with a nutritionist to help families identify foods high in sugar. Removal of foods and drinks high in free sugar from the home. Counseling using motivational interviewing, patient-centered goal setting to help parents and participating youth identify barriers to compliance with the intervention. Provision of a study provided LFSD with sufficient quantity to meet the needs and adapted to meet the preferences of the entire household for the first 4 weeks. Facilitated grocery shopping trips every 3 months during year 1.
Eligibility Criteria
You may qualify if:
- At least one parent or the child self-identifies as Hispanic or Latino.
- BMI ≥ 50th percentile for age and sex.
- Age ≥ 6 years and ≤ 9 years
- Tanner stage 1 by self and/or parental report
- Normal ALT on screening labs (≤23 IU for girls, ≤26 IU for boys)
- Written informed consent from parent or legal guardian, assent from child
You may not qualify if:
- Known diagnosis of chronic liver disease other than NAFLD and "fatty liver"
- History of significant depression
- Implanted metal or other implant (braces ok), or claustrophobia or other reason that contraindicates MRI
- Type 2 diabetes (Hemoglobin A1c \> 6.4% on screening labs or chronic diagnosis)
- Plans to move within the next 12 months
- Current or previous participation in a weight loss program or obesity treatment program or clinic
- Cancer or history of cancer
- Recipient of a liver transplant
- Chronic use (in the last year) of medications known to cause NAFLD or fatty liver (TPN, amiodarone, chronic oral steroids, etc.)
- Intellectual disability or major psychiatric disorder limiting informed assent
- At risk for eating disorder by screening instrument
- Participants who are currently enrolled in a clinical trial or have received an investigational product within the last 60 days
- Participants who are not able or willing to comply with the diet protocol or have any other condition or circumstance that would impede compliance or hinder completion of the study in the opinion of the investigator
- Children who spend more than 1 night per week consistently in another household
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute of Nursing Research (NINR)collaborator
Study Sites (1)
Emory University
Atlanta, Georgia, 30329, United States
Related Publications (1)
Welsh JA, Pyo E, Huneault H, Gonzalez Ramirez L, Alazraki A, Alli R, Dunbar SB, Khanna G, Knight-Scott J, Pimentel A, Reed B, Rodney-Somersall C, Santoro N, Umpierrez G, Vos MB. Study protocol for a randomized, controlled trial using a novel, family-centered diet treatment to prevent nonalcoholic fatty liver disease in Hispanic children. Contemp Clin Trials. 2023 Jun;129:107170. doi: 10.1016/j.cct.2023.107170. Epub 2023 Apr 3.
PMID: 37019180DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean Welsh, PhD, MPH, RN
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 15, 2022
First Posted
March 23, 2022
Study Start
April 6, 2022
Primary Completion
March 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
March 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be made available 6 months after publication. Applications must be submitted within 24 months of publication date.
- Access Criteria
- Researchers who provide a methodologically sound proposal, to achieve aims in an approved proposal. Access will be granted by submitting written detailed proposal to the corresponding author of the published article.
De-identified data underlying published findings